European Journal of Medicinal Chemistry (2020)
Update date:2022-08-15
Topics:
Kang, Hee
Ku, Jin-Mo
Lee, Jung-hun
Lee, Sukchan
Park, Kye Won
Roh, Kangsan
Song, Youngju
Herein, we demonstrate that butein (1) can prevent swelling in a murine lymphedema model by suppressing tumor necrosis factor α (TNF-α) production. Butein derivatives were synthesized and evaluated to identify compounds with in vitro anti-inflammatory activity. Among them, 20 μM of compounds 7j, 7m, and 14a showed 50percent suppression of TNF-α production in mouse peritoneal macrophages after lipopolysaccharide stimulation. Compound 14a, exhibited the strongest potency with an in vitro IC50 of 14.6 μM and suppressed limb volume by 70percent in a murine lymphedema model. The prodrug strategy enabled a six-fold increase in kinetic solubility of compound 1 and five-fold higher levels of active metabolite in the blood for compound 14a via oral administration in the pharmacokinetics study. We suggest that the compound 14a could be developed as a potential therapeutic agent targeting anti-inflammatory activity to alleviate lymphedema progression.
View MoreChiral Quest (Suzhou) Company Ltd
website:http://www.chiralquest.com
Contact:+86-0512-62956066
Address:B1/9, 218 Xinghu Street, Suzhou Industrial Park
Contact:(1) 206-3550089
Address:5115 NE 8TH PL, Renton, WA 98059 USA
Ji'nan Orgachem Pharmaceutical Co.,Ltd
Contact:+86-531-82687810
Address:Jinan
Shandong Yuanli Science and Technology Co., Ltd.
Contact:86-0536-6777557
Address:Zhuliu Industiral Park,Changle County
Contact:+86-15527136576
Address:Wuhan city
Doi:10.1002/jhet.774
(2012)Doi:10.1039/c2cc17802h
(2012)Doi:10.1016/j.ica.2012.01.007
(2012)Doi:10.1007/BF00798791
(1985)Doi:10.1016/j.ejps.2020.105513
(2020)Doi:10.1021/jacs.7b11299
(2018)